“Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study”, J of Skin, vol. 7, no. 6, p. s293, Nov. 2023, doi: 10.25251/skin.7.supp.293.